IP Library Granted Patent US 10,266,834
Granted Patent B2
US 10,266,834 · App. 15/236,144 · Granted Apr 23, 2019

Recombinant RNA particles and methods of producing proteins

Inventors: Robert C. Brown (San Diego, CA); Kurt I. Kamrud (San Diego, CA)
Assignee: Synthetic Genomics, Inc.
C12N15/81A61K39/0005A61K39/292C07K14/005C07K14/43509C07K14/745C07K16/1018C12N7/00C12N9/62C12N9/78C12N15/62C12Y305/04023A61K2039/53C07K2317/14C07K2317/24C12N2720/00021C12N2720/00034C12N2720/00043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,266,834
App. No.
15/236,144
Granted
Apr 23, 2019
Kind
B2
Abstract

The present invention provides compositions and methods for the production and delivery of recombinant double-stranded RNA molecules (dsRNA) encoding heterologous proteins, which can be useful for various therapeutic purposes as well as for the production of desired proteins. The compositions contain engineered double-stranded RNA particles (dsRPs) that can contain a double-stranded RNA molecule that can be a genome or portion of a genome, which can be enclosed in a capsid or coat protein. The dsRNA molecule also comprises an RNA sub-sequence that encodes a heterologous protein. The dsRPs can be derived from wild-type viral organisms. The delivery of the dsRPs (or DNA or RNA molecules) of the invention to an organism provides for therapeutic benefits as well as for the production of desired proteins.

Claims (39)

1. A double-stranded RNA particle (dsRP) comprising

a recombinant double-stranded RNA molecule (dsRNA) comprising,

at least one heterologous RNA sub-sequence that encodes a heterologous protein,

wherein the recombinant dsRNA molecule has at least 90% sequence identity with a wild type L-A viral genome, not counting the RNA sub-sequence that encodes the heterologous protein, and encodes a gag protein and an RNA-dependent RNA polymerase, and is sufficient for autonomous replication in a yeast host cell;

encapsidated in a capsid.

2. The dsRP of claim 1 wherein the host cell is a Saccharomyces cerevesiae.

3. The dsRP of claim 1 wherein the heterologous protein performs a function that affects an organism outside of the host cell.

4. The dsRP of claim 3 wherein the affect is to inhibit the growth of or kill a bacterial organism.

5. The dsRP of claim 3 wherein the heterologous protein is an enzyme that is exported from the host cell.

6. The dsRP of claim 1 wherein the heterologous protein is an enzyme selected from the group consisting of: a cellulase, a hemicellulase, a ligninase, a lignin peroxidase, an amylase, a lipase, a mannase, a glucanase, a protease, a betaglucanase, an amyloglucosidase, a pullulanase, an acetolactate decarboxylase (ALDC), a nuclease, a DNA ligase, a polymerase, a xylanase, a papain, a rennin, a trypsin, a chymosin, a subtilisin, and a chymotrypsin.

7. The dsRP of claim 1 wherein the RNA sub-sequence encodes an antibody, an epitope to a B cell or T cell, or an immunostimulatory peptide.

8. The dsRP of claim 7 wherein the RNA sub-sequence encodes an antibody.

9. The dsRP of claim 1 , wherein the RNA sub-sequence encodes a T-cell or B cell epitope.

10. The dsRP of claim 9 wherein the T cell or B cell epitope is displayed on the surface of the capsid or coat protein.

11. A method of producing a protein product in a host cell comprising:

transfecting a host cell with a dsRP of claim 1 ,

wherein the protein product is produced.

12. The method of claim 11 , further comprising harvesting the protein product.

13. The method of claim 11 wherein the host cell is a yeast.

14. The method of claim 11 wherein the dsRP is derived from a virus of the Totiviridae family.

15. The method of claim 11 wherein the RNA sub-sequence encodes a T-cell or B cell epitope, and the T cell or B cell epitope is expressed on the surface of the capsid or coat protein.

16. The method of claim 11 further comprising that the T cell or B cell epitope is expressed on the surface of the host cell.

17. The method of claim 11 wherein the protein product is an enzyme selected from the group consisting of: a cellulase, a hemicellulase, a ligninase, a lignin peroxidase, an amylase, a lipase, a mannase, a glucanase, a protease, a betaglucanase, an amyloglucosidase, a pullulanase, an acetolactate decarboxylase (ALDC), a nuclease, a DNA ligase, a polymerase, a xylanase, a papain, a rennin, a trypsin, a chymosin, a subtilisin, and a chymotrypsin.

18. A DNA vector comprising a sequence coding for a recombinant double-stranded RNA molecule (dsRNA) of claim 1 .

19. An RNA molecule translatable by a host cell and encoding at least one heterologous RNA sub-sequence that encodes a heterologous protein that is translated by the host cell cellular components, and wherein the recombinant dsRNA molecule has at least 90% sequence identity with a wild type L-A viral genome, not counting the RNA sub-sequence that encodes the functional protein, and encodes a gag protein and an RNA-dependent RNA polymerase, and is sufficient for autonomous replication in a yeast host cell.

20. The RNA molecule of claim 19 comprising a viral genome.

21. The RNA molecule of claim 19 wherein the wild-type virus is an L-A virus of the Totiviridae family.

22. A method of producing a protein product in a host cell comprising:

a) transfecting the host cell with an RNA or DNA molecule encoding:

i) an RNA-dependent RNA polymerase; and

ii) a polyprotein that, when translated, forms at least part of a capsid or coat protein and creates a dsRP able to replicate in a host cell;

iii) the RNA molecule further comprising at least one heterologous RNA subsequence that encodes the protein product that is translated by cellular components of the host cell and that is heterologous to the host cell;

wherein the RNA or DNA molecule has at least 90% sequence identity with a wild type L-A virus genome, not counting the RNA sub-sequence encoding the heterologous protein product; and

b) wherein the protein product is produced.

23. The method of claim 22 wherein the host cell is a yeast.

24. The method of claim 23 wherein the dsRP is derived from a virus of the Totiviridae family and the protein product is also heterologous to the virus the dsRP is derived from.

25. The method of claim 23 wherein the RNA sub-sequence encodes a T-cell or B cell epitope, and the T cell or B cell epitope is expressed on the surface of the capsid or coat protein.

26. The method of claim 23 further comprising that the T cell or B cell epitope is expressed on the surface of the host cell.

27. The method of claim 23 wherein the protein product is an enzyme selected from the group consisting of: a cellulase, a hemicellulase, a ligninase, a lignin peroxidase, an amylase, a lipase, a mannase, a glucanase, a protease, a betaglucanase, an amyloglucosidase, a pullulanase, an acetolactate decarboxylase (ALDC), a nuclease, a DNA ligase, a polymerase, a xylanase, a papain, a rennin, a trypsin, a chymosin, a subtilisin, and a chymotrypsin.

Assignments (6)
CHANGE OF NAME Recorded Apr 7, 2022
From: SYNTHETIC GENOMICS, INC.
To: VIRIDOS, INC.
Reel/Frame 059631/0684 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
SECURITY INTEREST Recorded Mar 20, 2019
From: SYNTHETIC GENOMICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 048655/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2017
From: KAMRUD, KURT I.
To: SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 042662/0785 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2017
From: SYNTHETIC GENOMICS VACCINES, INC.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 042662/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2016
From: BROWN, ROBERT C.; KAMRUD, KURT I.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 039870/0381 →
Continuity (2)
Provisional Application 62204363 · Aug 12, 2015
Related Publication 20170044555A1 · Feb 16, 2017